207 related articles for article (PubMed ID: 7912041)
1. Evaluation of porphyria cutanea tarda in U.S. workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Calvert GM; Sweeney MH; Fingerhut MA; Hornung RW; Halperin WE
Am J Ind Med; 1994 Apr; 25(4):559-71. PubMed ID: 7912041
[TBL] [Abstract][Full Text] [Related]
2. Angiosarcoma, porphyria cutanea tarda, and probable chloracne in a worker exposed to waste oil contaminated with 2,3,7,8-tetrachlorodibenzo-p-dioxin.
McConnell R; Anderson K; Russell W; Anderson KE; Clapp R; Silbergeld EK; Landrigan PJ
Br J Ind Med; 1993 Aug; 50(8):699-703. PubMed ID: 8104464
[TBL] [Abstract][Full Text] [Related]
3. Hepatic and gastrointestinal effects in an occupational cohort exposed to 2,3,7,8-tetrachlorodibenzo-para-dioxin.
Calvert GM; Hornung RW; Sweeney MH; Fingerhut MA; Halperin WE
JAMA; 1992 Apr 22-29; 267(16):2209-14. PubMed ID: 1348289
[TBL] [Abstract][Full Text] [Related]
4. Porphyrin studies in TCDD-exposed workers.
Jung D; Konietzko J; Reill-Konietzko G; Muttray A; Zimmermann-Hölz HJ; Doss M; Beck H; Edler L; Kopp-Schneider A
Arch Toxicol; 1994; 68(9):595-8. PubMed ID: 7998828
[TBL] [Abstract][Full Text] [Related]
5. Development of chronic hepatic porphyria (porphyria cutanea tarda) with inherited uroporphyrinogen decarboxylase deficiency under exposure to dioxin.
Doss M; Sauer H; von Tiepermann R; Colombi AM
Int J Biochem; 1984; 16(4):369-73. PubMed ID: 6714509
[TBL] [Abstract][Full Text] [Related]
6. Long-standing changes in the urinary profile of porphyrin isomers after clinical remission of porphyria cutanea tarda.
To-Figueras J; Ozalla D; Mateu CH
Ann Clin Lab Sci; 2003; 33(3):251-6. PubMed ID: 12956438
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of diabetes mellitus, serum glucose, and thyroid function among United States workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Calvert GM; Sweeney MH; Deddens J; Wall DK
Occup Environ Med; 1999 Apr; 56(4):270-6. PubMed ID: 10450245
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of chronic bronchitis, chronic obstructive pulmonary disease, and ventilatory function among workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Calvert GM; Sweeney MH; Morris JA; Fingerhut MA; Hornung RW; Halperin WE
Am Rev Respir Dis; 1991 Dec; 144(6):1302-6. PubMed ID: 1741543
[TBL] [Abstract][Full Text] [Related]
9. Abnormal urinary coproporphyrin levels in patients infected by hepatitis C virus with or without human immunodeficiency virus. A study of 177 patients.
Cribier B; Rey D; Uhl G; Le Coz C; Hirth C; Libbrecht E; Vetter D; Lang JM; Stoll-Keller F; Grosshans E
Arch Dermatol; 1996 Dec; 132(12):1448-52. PubMed ID: 8961873
[TBL] [Abstract][Full Text] [Related]
10. Porphyria cutanea tarda with constrictive pericarditis in a family.
Adachi S; Amano J; Ito H; Yajima T; Shirai T; Miyahara Y; Marumo F; Hiroe M
Jpn Heart J; 1997 Sep; 38(5):749-53. PubMed ID: 9462424
[TBL] [Abstract][Full Text] [Related]
11. The difference in liver pathology between sporadic and familial forms of porphyria cutanea tarda: the role of iron.
Siersema PD; Rademakers LH; Cleton MI; ten Kate FJ; de Bruijn WC; Marx JJ; Wilson JH
J Hepatol; 1995 Sep; 23(3):259-67. PubMed ID: 8550989
[TBL] [Abstract][Full Text] [Related]
12. Dual porphyria of coexisting variegata and cutanea tarda.
Sieg I; Bhutani LK; Doss MO
Eur J Clin Chem Clin Biochem; 1995 Jul; 33(7):405-10. PubMed ID: 7548446
[TBL] [Abstract][Full Text] [Related]
13. Interferon treatment of porphyria cutanea tarda associated with chronic hepatitis type C.
Okano J; Horie Y; Kawasaki H; Kondo M
Hepatogastroenterology; 1997; 44(14):525-8. PubMed ID: 9164531
[TBL] [Abstract][Full Text] [Related]
14. Correlation between levels of free and protein-bound plasma porphyrin and urinary porphyrins in porphyria cutanea tarda.
Moran MJ; Fontanellas A; Santos JL; Enriquez de Salamanca R
Int J Biochem Cell Biol; 1995 Jun; 27(6):585-8. PubMed ID: 7671136
[TBL] [Abstract][Full Text] [Related]
15. Immunological markers among workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Halperin W; Vogt R; Sweeney MH; Shopp G; Fingerhut M; Petersen M
Occup Environ Med; 1998 Nov; 55(11):742-9. PubMed ID: 9924450
[TBL] [Abstract][Full Text] [Related]
16. Porphyria cutanea tarda in three generations of a single family.
Benedetto AV; Kushner JP; Taylor JS
N Engl J Med; 1978 Feb; 298(7):358-62. PubMed ID: 622106
[TBL] [Abstract][Full Text] [Related]
17. Hepatotoxic reaction to chloroquine phosphate in a patient with previously unrecognized porphyria cutanea tarda.
Liu AC
West J Med; 1995 Jun; 162(6):548-51. PubMed ID: 7618323
[No Abstract] [Full Text] [Related]
18. Spontaneous abortion, sex ratio, and paternal occupational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Schnorr TM; Lawson CC; Whelan EA; Dankovic DA; Deddens JA; Piacitelli LA; Reefhuis J; Sweeney MH; Connally LB; Fingerhut MA
Environ Health Perspect; 2001 Nov; 109(11):1127-32. PubMed ID: 11712997
[TBL] [Abstract][Full Text] [Related]
19. Further discussion concerning porphyria cutanea tarda and TCDD exposure.
Jones RE; Chelsky M
Arch Environ Health; 1986; 41(2):100-3. PubMed ID: 3521500
[TBL] [Abstract][Full Text] [Related]
20. ACQUIRED PORPHYRIA CUTANEA TARDA: REPORT OF A CASE SUCCESSFULLY TREATED BY PHLEBOTOMY.
KOVAL A; DANBY CW; PETERMANN H
Can Med Assoc J; 1965 Sep; 93(10):537-40. PubMed ID: 14341652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
